Hepatitis C Management in Special Populations

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 8/17/18 (What's New)


  • Drug–drug interactions between HCV therapy and ART is the primary consideration when selecting DAA therapy in HCV/HIV-coinfected patients
  • The AASLD/IDSA and EASL provide recommendations on the use of certain HCV therapies with ART (Table 11)

Action required